Neogenomics raises target price to $20 from $16
NEO•StoneX raised its target price for Neogenomics to $20 from $16.
Related News
Lazard target price cut to $38 from $45
LAZ•
Spyre Therapeutics slips on $350 million share sale
SYRE•
Auddia cancels Oct. 7 shareholder meeting, plans to reset record date for merger vote
AUUD•
Goldman Sachs: BMO cuts target price to $970 from $972
GS•
GEO Group to redeem $650 million senior secured notes on Oct. 15, 2026
GEO•